The 7 linked references in paper E. Kropacheva S., O. Zemlyanskaya A., E. Panchenko P., A. Dobrovolsky B., E. Krivosheeva N., Е. Кропачева С., О. Землянская А., Е. Панченко П., А. Добровольский Б., Е. Кривошеева Н. (2017) “БЕЗОПАСНОСТЬ ДЛИТЕЛЬНОЙ ТЕРАПИИ ВАРФАРИНОМ: ЧАСТОТА КРОВОТЕЧЕНИЙ И КЛИНИЧЕСКИЕ ПРЕДИКТОРЫ ИХ РАЗВИТИЯ (результаты проспективного 15-летнего наблюдения) // SAFETY OF LONG-TERM THERAPY WITH WARFARIN: HEMORRHAGE FREQUENCY AND CLINICAL PREDICTORS (results of a prospective 15-year follow-up)” / spz:neicon:aterotromboz:y:2017:i:1:p:145-162

  1. Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest, 2012, 141(2 Suppl): e637S-68S. doi: 10.1378/chest.11-2306. pmid: 22315274.
  2. Антитромботическая терапия у больных со стабильными проявлениями атеротромбоза. Российские рекомендации. Кардиоваскулярная терапия и профилактика, 2009, 8(6).
  3. Connolly SJ, Ezekowitz MD, Salim Yusuf et al and the RE-LY Steering Committee and Investigators. Dabigatran versus Warfarin in Patients with Atrial Fibrillation. N Engl J Med,2009, September 17, 361: 1139-1151. DOI: 10.1056/NEJMoa090556123.
  4. Vranckx P, White HD, Huang Z et al. Validation of BARC Bleeding Criteria in Patients With Acute Coronary Syndromes: The TRACER Trial. J Am CollCardiol, 2016, 67(18): 2135-44. doi: 10.1016/j.jacc.2016.02.05.
  5. Choi JH, Seo JM, Lee DH et al. Clinical utility of new bleeding criteria: a prospective study of evaluation for the Bleeding Academic Research Consortium definition of bleeding in patients undergoing percutaneous coronary intervention. J Cardiol, 2015, 65(4): 324-9. doi: 10.1016/j.jjcc.2014.06.011.
  6. Chen CF, Chen B, Zhu J, Xu YZ. Antithrombotic therapy after percutaneous coronary intervention in patients requiring oral anticoagulant treatment. A meta-analysis. Herz,2015, 40(8): 1070-83. doi: 10.1007/s00059-015-4325-0.
  7. Kirchhof P, Benussi S, Kotecha D et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J.ю 2016, 37(38): 2893-2962. DOI: https: //doi.org/10.1093/eurheartj/ehw210.